Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision tag, v3.5.4, has been added to the page, replacing the previous v3.5.3. This signals a back-end/content update, while the study details remain unchanged.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe footer revision identifier was updated from v3.5.2 to v3.5.3, indicating a change to the site/versioning of the page itself rather than to the clinical trial record.SummaryDifference0.0%

- Check40 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision log updated: added Revision v3.5.0; removed Revision v3.4.3.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision update applied: v3.4.3 replacing the previous v3.4.2.SummaryDifference0.0%

- Check105 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.